Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Change in Cash (2016 - 2026)

Pharma-Bio Serv's Change in Cash history spans 17 years, with the latest figure at $2.4 million for Q1 2026.

  • For Q1 2026, Change in Cash rose 341.75% year-over-year to $2.4 million; the TTM value through Jan 2026 reached -$1.5 million, down 272.73%, while the annual FY2025 figure was -$3.4 million, 7.9% up from the prior year.
  • Change in Cash reached $2.4 million in Q1 2026 per PBSV's latest filing, up from -$578540.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $7.6 million in Q4 2023 to a low of -$7.2 million in Q1 2023.
  • Average Change in Cash over 5 years is -$688513.4, with a median of $223900.0 recorded in 2022.
  • The largest YoY upside for Change in Cash was 3283.86% in 2023 against a maximum downside of 586.3% in 2023.
  • A 5-year view of Change in Cash shows it stood at $223900.0 in 2022, then soared by 3283.86% to $7.6 million in 2023, then plummeted by 96.74% to $247174.0 in 2024, then crashed by 334.06% to -$578540.0 in 2025, then soared by 512.14% to $2.4 million in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Change in Cash are $2.4 million (Q1 2026), -$578540.0 (Q4 2025), and $1.9 million (Q3 2025).